Yao Li

A multicenter, real‐world study on effectiveness and safety of first‐line modified PD‐1 inhibitors with chemotherapy in advanced non‐small cell lung cancer (aNSCLC) with drive gene‐negative

Lei Zhao, L. Qiu, Fan Zhang, 2024, Cancer medicine.